Gut+ Probiotic

About GUT+ Probiotic

At OXYZ, we believe that true wellness starts in the gut. GUT+ Probiotic was developed using a patented Danish strain of Lactobacillus reuteri DSM17648, specifically selected to target and reduce harmful Helicobacter pylori bacteria without disturbing the good bacteria your body needs.

We understand that digestive health affects everything from mood to immunity, which is why GUT+ goes beyond traditional probiotics. It’s safe for kids, pregnant women, and anyone looking for a natural, effective solution to chronic stomach issues.

Whether you’re dealing with acid reflux, bloating, or just want to improve your digestion and well-being, GUT+ helps you regain control of your health — naturally and effectively.

Clinically Proven for

Loaded with 20 billion CFU of Pylopass, the Denmark patented strain of Lactobacillus reuteri, for improving Stomach and Digestive Health. Backed by many clinical studies, Pylopass is a proven strain with safe and natural approach to reduce class 1 carcinogen bacteria – Helicobacter pylori bacterial load and improve gastrointestinal symptoms such as heartburn, acid reflux, bloating, gastritis, stomach discomfort etc. Each serving of >GUT+ Probiotic contains:

200 mg of Dietary Fiber & Prebiotics
200 mg of Pylopass Lactobacillus reuteri DSM17648
30 capsules per box

How it Works

Gut Health Matters

Hippocrates, the father of medicine, once said “All disease begins in the gut.” While all disease doesn’t literally start in the gut, but many research findings confirm that many metabolic, autoimmune, and cognitive diseases do in fact start with gastrointestinal disturbances or imbalances. These findings highlight the fact that we cannot achieve optimal health without a healthy gut.

The gut, otherwise known as the large intestine hosts trillions of bacteria, fungi and other organisms. It also houses 70% of our immune cells, the majority of neurotransmitter production, influences our metabolism, contributes to energy homeostasis, and so much more.

People incorrectly assume that an absence of gastrointestinal symptoms equates to a healthy gut but that is far from true. While digestive symptoms such as bloating, gas, constipation, diarrhea, abdominal pain, etc. are very common, it’s also almost just as common for symptoms to present neurologically.

Gut disturbances often result in symptoms such as brain fog, poor concentration, poor memory, depression and anxiety. This is because the gut and the brain are in constant communication via the gut-brain axis. That means poor gut function can lead to poor brain function. Other areas that are closely affected by the gut include the skin, immune system (and risk of autoimmune disease), blood sugar regulation, detoxification and cell mitochondria metabolism.

Who Should Take GUT+ Probiotic

GUT+ is ideal for anyone looking to improve digestion, fight harmful bacteria naturally, and reduce reliance on antibiotics. Whether you’re dealing with long-term gut issues or just want a daily probiotic boost, GUT+ gives your body the support it deserves — safely and effectively.

Class 1 Carcinogen Bacteria - Helicobacter pylori

Helicobacter pylori is classified as class 1 carcinogen by World Health Organization in 1994. There is sufficient evidence in humans for the carcinogenicity of infection with Helicobacter pylori. Tons of people suffer from digestive issues such as bloating, gas, acid reflux, heartburn, and stomach discomfort which is directly link to Helicobacter pylori infections.

Helicobacter pylori is a pathogenic bacterium commonly found in the stomach and digestive tract and it shows very strong tendency to attack the stomach lining. It can also live in our digestive tract for many years and cause stomach ulcers. Chronic infection with Helicobacter pylori causes atrophic and even metaplastic changes in the stomach, and it has been a well-known association with gastritis and peptic ulcer.

Surprisingly, infection with Helicobacter pylori is very common. About 70% of the world’s population has it in their bodies. In general, 80% of patients infected with Helicobacter pylori are asymptomatic, and it can live in the body for years before symptoms start.

Inflammation of, or damage to the stomach lining (Gastritis) by Helicobacter pylori may cause mild or serious reactions to the stomach’s contents, such as stomach ache or abdominal pain, acid reflux, nausea, and vomiting. Patients infected with Helicobacter pylori will experience bad breath and frequent hunger as well.

If untreated for a long time, Helicobacter pylori infections may be related to several serious illnesses: gastroesophageal reflux disease (GERD), peptic ulcer (duodenal or gastric ulcer), and cancers of esophagus and stomach.

Risk of Antibiotic Resistance

In general, Helicobacter pylori infection is treated with “triple therapy” as the first line treatment option, which includes two kinds of antibiotics to ‘eradicate’ Helicobacter pylori, together with proton pump inhibitor to reduce gastric acid concentration, ulcer irritation and help recovery. However, this option has fallen out of favor because growing resistance to the standard triple therapy has made eradication of Helicobacter pylori a global challenge. Diminishing success of triple therapy is due to growing clarithromycin and metronidazole resistance, which occurs in up to 50% of cases.

Antibiotic resistance is an alarming issue and a global health priority as announced by World Health Organization. In 2016, 700,000 deaths annually worldwide which every 45 seconds a person dies from an antibiotic resistant infection. An estimated of 10 million deaths a year by 2050 was forecasted. To successfully treat these patients, a multifactorial approach must consider antibiotic resistance and optimization of medication regimens that provide ease of adherence.